City National Bank’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$2.11M Buy
77,728
+496
+0.6% +$14K 0.02% 353
2015
Q2
$2.12M Buy
77,232
+1,392
+2% +$39.1K 0.02% 384
2015
Q1
$2.02M Sell
75,840
-6,230
-8% -$143K 0.02% 388
2014
Q4
$1.74M Buy
82,070
+6,536
+9% +$146K 0.02% 406
2014
Q3
$1.8M Sell
75,534
-15,468
-17% -$356K 0.02% 400
2014
Q2
$2.1M Buy
91,002
+49,902
+121% +$1.1M 0.02% 385
2014
Q1
$939K Sell
41,100
-1,200
-3% -$25.6K 0.01% 428
2013
Q4
$782K Buy
42,300
+550
+1% +$9.59K 0.01% 477
2013
Q3
$707K Sell
41,750
-2,380
-5% -$40K 0.01% 455
2013
Q2
$684K Buy
+44,130
New +$735K 0.01% 470

Other funds holding NVO

City National Bank's NVO Position: Q3 2015 in Review

City National Bank increased its Novo Nordisk (NVO) stake by 0.64% in Q3 2015, buying an estimated $14K and bringing the position to 77,728 shares worth $2.11M. The position accounts for 0.02% of the portfolio, ranked #353.

City National Bank first reported a position in NVO in Q2 2013 and has held it in 10 quarters since. The position peaked at $2.12M in Q2 2015. 525 funds tracked by Wall St. Rank hold NVO as of Q3 2015.

  • City National Bank held 77,728 shares of Novo Nordisk worth $2.11M as of Q3 2015.
  • City National Bank bought 496 Novo Nordisk shares in Q3 2015, an estimated $14K.
  • Novo Nordisk made up 0.02% of City National Bank's portfolio in Q3 2015, its #353 holding.
  • City National Bank first reported a position in Novo Nordisk in Q2 2013 and has held it in 10 quarters since.
  • City National Bank's Novo Nordisk position peaked at $2.12M in Q2 2015.
  • 525 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2015.

Based on City National Bank's 13F filing for Q3 2015, filed 29 Oct 2015.